Life Sciences Blog

China issues revised requirements on pharmaceutical wholesalers and retailers

Posted on July 9th, by Michael Shapiro-Barr

China’s Ministry of Health has released revised requirements on pharmaceutical wholesalers and retailers in China.  The revised “Good Supply Practice of Pharmaceutical Products” provides that a detailed implementation plan for the new standards shall be formulated by China’s State Food and Drug Administration (SFDA).  A compliance deadline of December 31, 2014 is in place for wholesale enterprises entrusted with drug storage and distribution of the following pharmaceutical products:

  • Vaccines
  • Narcotic drugs
  • Psychotropic substances
  • Anabolic agents
  • Peptide hormones

Read More



Comments are closed.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

Navigating the Isolated DNA Patent Eligibility Jungle
Introduction

For over 150 years the Supreme Court has provided three categories of exceptions to patent eligibility under 35 U.S.C §101:  abstract ideas, laws of...

Drug Import Regulation: On the Brink of Historic Change

On Friday, July 12, 2013, the Food and Drug Administration (FDA) hosted a public meeting to discuss the implementation of the drug supply chain...

This Conversation May Be Recorded

As the pharmaceutical industry changes, it must take note of the impact such change has on employee relations and the potential for lawsuits.  Big...